AA
TVGNW icon

AQR Arbitrage’s Tevogen Bio Warrant TVGNW Stock Holding History

AQR Arbitrage’s Portfolio TVGNW Stock Details TVGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-236,314
Closed -$9.45K – 645
2023
Q4 		$9.45K Hold
236,314
– – ﹤0.01% 514
2023
Q3 		$15.5K Hold
236,314
– – ﹤0.01% 566
2023
Q2 		$9.74K Sell
236,314
-1,945
-0.8% -$105 ﹤0.01% 713
2023
Q1 		$12K Sell
238,259
-9,356
-4% -$517 ﹤0.01% 834
2022
Q4 		$1.86K Hold
247,615
– – ﹤0.01% 1130
2022
Q3 		$30K Hold
247,615
– – ﹤0.01% 924
2022
Q2 		$40K Hold
247,615
– – ﹤0.01% 945
2022
Q1 		$67K Buy
+247,615
New +$92.1K ﹤0.01% 854

Other funds holding TVGNW

FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

AQR Arbitrage's TVGNW Position: Q1 2024 in Review

AQR Arbitrage sold out of Tevogen Bio Warrant (TVGNW) in Q1 2024, closing a stake of 236,314 shares — an estimated $9.45K sold.

AQR Arbitrage first reported a position in TVGNW in Q1 2022 and held it in 8 quarters. The position peaked at $67K in Q1 2022. 41 funds tracked by Wall St. Rank hold TVGNW as of Q1 2024.

  • AQR Arbitrage reported no remaining Tevogen Bio Warrant position as of Q1 2024 after selling out during the quarter.
  • AQR Arbitrage sold 236,314 Tevogen Bio Warrant shares in Q1 2024, an estimated $9.45K.
  • AQR Arbitrage first reported a position in Tevogen Bio Warrant in Q1 2022 and held it in 8 quarters.
  • AQR Arbitrage's Tevogen Bio Warrant position peaked at $67K in Q1 2022.
  • 41 funds tracked by Wall St. Rank held Tevogen Bio Warrant as of Q1 2024.

Based on AQR Arbitrage's 13F filing for Q1 2024, filed 15 May 2024.